---
title: "截止日期提醒：Faruqi & Faruqi 律师事务所代表 Altimmune 的投资者进行索赔调查"
description: "Faruqi & Faruqi, LLP 正在代表在 2023 年 8 月 10 日至 2025 年 6 月 25 日期间在 Altimmune, Inc. 中遭受超过 $75,000 损失的投资者调查索赔。投资者被鼓励在 2025 年 10 月 6 日的截止日期之前联系合伙人 Josh Wilson，了解他们在联邦证券集体诉讼中寻求主要原告资格的法律权利。在令人失望的试验结果后，Altimmun"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/251882441.md"
published_at: "2025-08-06T17:39:54.000Z"
---

# 截止日期提醒：Faruqi & Faruqi 律师事务所代表 Altimmune 的投资者进行索赔调查

> Faruqi & Faruqi, LLP 正在代表在 2023 年 8 月 10 日至 2025 年 6 月 25 日期间在 Altimmune, Inc. 中遭受超过 $75,000 损失的投资者调查索赔。投资者被鼓励在 2025 年 10 月 6 日的截止日期之前联系合伙人 Josh Wilson，了解他们在联邦证券集体诉讼中寻求主要原告资格的法律权利。在令人失望的试验结果后，Altimmune 的股价在一天内暴跌 53.2%，从每股 $7.71 降至 $3.61。该公司邀请任何拥有关于 Altimmune 行为信息的人与其联系

Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Altimmune To Contact Him Directly To Discuss Their Options.

### Related Stocks

- [ALT.US - Altimmune](https://longbridge.com/zh-CN/quote/ALT.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Altimmune Director Wayne Pisano Acquires Common Shares | Wayne Pisano, Director at Altimmune Inc., has acquired common shares of the company. The full filing is available throug | [Link](https://longbridge.com/zh-CN/news/272122963.md) |
| Altimmune Inc. Director Catherine A. Sohn Reports Acquisition of Common Shares | Catherine A. Sohn, Director at Altimmune Inc., has reported the acquisition of common shares of the company. The full fi | [Link](https://longbridge.com/zh-CN/news/271563101.md) |
| Altimmune Earns FDA Breakthrough Therapy Designation for Pemvidutide in MASH | Altimmune Inc. has received FDA Breakthrough Therapy Designation for pemvidutide, a dual receptor agonist for treating m | [Link](https://longbridge.com/zh-CN/news/271512829.md) |
| Altimmune Director Diane Jorkasky Acquires Common Shares | Diane Jorkasky, a Director at Altimmune Inc., has acquired common shares of the company. The full filing is available th | [Link](https://longbridge.com/zh-CN/news/271030324.md) |
| Altimmune Director John Gill Reports Acquisition of Common Shares | John Gill, Director at Altimmune Inc., has acquired common shares of the company. This event was reported through a fili | [Link](https://longbridge.com/zh-CN/news/270655085.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
